Synthesis of 99mTc-Radiolabeled Uridine as a Potential Tumor Imaging Agent

被引:1
|
作者
Talaat H.M. [1 ]
Ibrahim I.T. [1 ]
Bayomy N.A. [1 ]
Farouk N. [1 ]
机构
[1] Hot Laboratories Centre, Atomic Energy Authority, P.O. Box 13759, Cairo
关键词
radiopharmaceuticals; technetium-99m; tumor imaging; uridine;
D O I
10.1134/S1066362218010095
中图分类号
学科分类号
摘要
Uridine, a pyrimidine nucleoside essential for the synthesis of RNA and biomembranes, was radiolabeled with 99mTc to obtain a potential tumor imaging agent. The maximal radiochemical yield of about 96.5%, as determined by paper chromatography and instant thin-layer chromatography, was reached under the following optimum conditions: 1 mg of uridine, 20 μg of SnCl2·2H2O as reducing agent, 20 mg of mannitol as a stabilizer, and pH 8. 99mTc-uridine is stable in vitro at room temperature for up to 6 h post labeling. The biodistrbution study in tumor-bearing mice shows high target-to-nontarget ratio. These results match with the high docking score of the complex on uridine phosphorylase enzyme. 99mTc-uridine shows promise as a tumor imaging agent. © 2018, Pleiades Publishing, Inc.
引用
收藏
页码:51 / 57
页数:6
相关论文
共 50 条
  • [1] 99mTc-Radiolabeled TPGS Nanomicelles Outperform 99mTc-Sestamibi as Breast Cancer Imaging Agent
    Tesan, Fiorella C.
    Nicoud, Melisa B.
    Nunez, Mariel
    Medina, Vanina A.
    Chiappetta, Diego A.
    Salgueiro, Maria J.
    CONTRAST MEDIA & MOLECULAR IMAGING, 2019,
  • [2] 99mTc-radiolabeled HER2 targeted exosome for tumor imaging
    Molavipordanjani, Sajjad
    Khodashenas, Shabanali
    Abedi, Seyed Mohammad
    Moghadam, Mehdi Forouzandeh
    Mardanshahi, Alireza
    Hosseinimehr, Seyed Jalal
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 148
  • [3] Evaluation of a new radiolabeled bombesin derivative with 99mTc as potential targeted tumor imaging agent
    Sadeghzadeh, N.
    Ahmadzadeh, M.
    Erfani, M.
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2013, 298 (01) : 287 - 293
  • [4] Evaluation of a new radiolabeled bombesin derivative with 99mTc as potential targeted tumor imaging agent
    N. Sadeghzadeh
    M. Ahmadzadeh
    M. Erfani
    Journal of Radioanalytical and Nuclear Chemistry, 2013, 298 : 287 - 293
  • [5] 99mTc-radiolabeled GE11-modified peptide for ovarian tumor targeting
    Rahmanian, Najmeh
    Hosseinimehr, Seyed Jalal
    Khalaj, Ali
    Noaparast, Zohreh
    Abedi, Seyed Mohammad
    Sabzevari, Omid
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 25
  • [6] Optimized Preparation of a 99mTc-Radiolabeled Probe for Tracing MicroRNA
    Kang, Lei
    Xu, Xiao-jie
    Ma, Chao
    Wang, Rong-fu
    Yan, Ping
    Zhang, Chun-li
    Sun, Hong-wei
    Li, Ding
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 71 (02) : 905 - 912
  • [7] Optimized Preparation of a 99mTc-Radiolabeled Probe for Tracing MicroRNA
    Lei Kang
    Xiao-jie Xu
    Chao Ma
    Rong-fu Wang
    Ping Yan
    Chun-li Zhang
    Hong-wei Sun
    Ding Li
    Cell Biochemistry and Biophysics, 2015, 71 : 905 - 912
  • [8] 99mTc-radiolabeled GE11-modified peptide for ovarian tumor targeting
    Najmeh Rahmanian
    Seyed Jalal Hosseinimehr
    Ali Khalaj
    Zohreh Noaparast
    Seyed Mohammad Abedi
    Omid Sabzevari
    DARU Journal of Pharmaceutical Sciences, 25
  • [9] 99mTc-radiolabeled cubosomes for targeting the lymphatic system in vivo
    Nilsson, Christa
    Kallinen, Annukka
    Raki, Mari
    Airaksinen, Anu J.
    Urtti, Arto
    Yaghmur, Anan
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S191 - S191
  • [10] Tumor Imaging in Patients with Advanced Tumors Using a New 99mTc-Radiolabeled Vitamin B12 Derivative
    Sah, Bert-Ram
    Schibli, Roger
    Waibel, Robert
    von Boehmer, Lotta
    Blaeuenstein, Peter
    Nexo, Ebba
    Johayem, Anass
    Fischer, Eliane
    Mueller, Ennio
    Soyka, Jan D.
    Knuth, Alexander K.
    Haerle, Stefan K.
    Schubiger, Pius August
    Schaefer, Niklaus G.
    Burger, Irene A.
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (01) : 43 - 49